Mary Lechowicz MD
Academic Appointment
- Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from State University of New York, New York
- BA from Hofstra University, Hempstead
Research
Focus
- My research focus is virally-related and T -cell lymphomas through clinical trial design, implementation, and correlative research with basic scientists. These populations are rare diseases with less emphasis on clinical research and standard of care options. I develop collaborations throughout the country to improve awareness, outcomes, and knowledge about these diseases.
Publications
-
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.
Blood Adv Volume: 9 Page(s): 1952 - 1965
04/22/2025 Authors: Pierson SK; Brandstadter JD; Torigian DA; Bagg A; Lechowicz MJ; Alapat D; Casper C; Chadburn A; Chandrakasan S; Dispenzieri A -
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Szary Syndrome.
Transplant Cell Ther Volume: 30 Page(s): 1047 - 1060
11/01/2024 Authors: Goyal A; O'Leary D; Dabaja B; Weng W-K; Zain J; Cutler C; Guitart J; Kim YH; Geskin LJ; Hoppe RT -
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.
Haematologica Volume: 109 Page(s): 2196 - 2206
07/01/2024 Authors: Bustamante MS; Pierson SK; Ren Y; Bagg A; Brandstadter JD; Srkalovic G; Mango N; Alapat D; Lechowicz MJ; Li H -
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis.
Int J Hematol Volume: 119 Page(s): 736 - 744
06/01/2024 Authors: Lechowicz MJ; Smith C; Ristuccia R; Dwyer K -
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study.
Haematologica Volume: 109 Page(s): 209 - 219
01/01/2024 Authors: Iyer SP; Huen A; Ai WZ; Jagadeesh D; Lechowicz MJ; Okada C; Feldman TA; Ghione P; Alderuccio JP; Champion R -
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
CNS Oncol Volume: 12 Page(s): CNS105
12/01/2023 Authors: Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB -
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes.
Blood Adv Volume: 7 Page(s): 6652 - 6664
11/14/2023 Authors: Pierson SK; Lim MS; Srkalovic G; Brandstadter JD; Sarmiento Bustamante M; Shyamsundar S; Mango N; Lavery C; Austin B; Alapat D -
Ongoing symptoms following complete surgical excision in unicentric Castleman disease.
Am J Hematol Volume: 98 Page(s): E334 - E337
11/01/2023 Authors: Sarmiento Bustamante M; Shyamsundar S; Coren FR; Bagg A; Srkalovic G; Alapat D; van Rhee F; Lim MS; Lechowicz MJ; Brandstadter JD -
Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.
Clin Lymphoma Myeloma Leuk Volume: 23 Page(s): 667 - 673
09/01/2023 Authors: Zhuang TZ; McCook-Veal A; Switchenko J; Niyogusaba T; Tarabadkar ES; Baird K; O'Leary C; Paulino D; Lechowicz MJ; Allen PB -
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol Volume: 202 Page(s): 525 - 529
08/01/2023 Authors: Stuver R; Horwitz SM; Advani RH; Vose JM; Lee HJ; Mehta-Shah N; Zain JM; Haverkos B; Lechowicz MJ; Moskowitz AJ